Chemical Structure (Levetiracetam 01)
Levetiracetam Tablet, Film Coated, Extended Release
Product Images NDC 71205-880
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 71205-880). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Levetiracetam 02)
This appears to be a table or chart showing the percentages of patients taking different medications. The medications listed are "Plaoebo", "Immediate-release levetraoetam 1000 mg/day", and "Immedise-relezse levetiraoetam 3000 mg/day". The numbers listed appear to be the percentage of patients taking each medication, with Plaoebo being the most common at 39.6%. The accuracy of the medication names is uncertain due to the errors.*
Figure 2 (Levetiracetam 03)
This appears to be a graph or chart showing the results of a study with different percentages of patients and treatment effectiveness. However, without additional context or a clear description, it is difficult to provide a more specific interpretation or use for this information.*
Figure 3 (Levetiracetam 04)
This appears to be a graph showing the percentage of patients on the Y axis and different treatments on the X axis. The treatments listed are placebo, immediate-release, and Levetroacetam at a dosage of 3,000 mg/day. The graph shows that the percentage of patients for each treatment decreases as the treatments become more effective, with the highest percentage being for the placebo group at 39.4%.*
Figure 4 (Levetiracetam 05)
71205-880-30 (Levetiracetam 06)
Levetiracetam 500mg is a pharmaceutical product presented as #30 ER film-coated tablets designed for once daily dosing, meant to be dispensed with an enclosed medication guide for the patient. Each tablet contains 500mg of Levetiracetam USP. The shape of the tablets is oval, coated with a white color, marked with "SG" on one side and "109" on the other. The product ID is QL088030 manufactured by ScioGanPramaseutca o, Hawoauge NY 11788. The medication should be stored at a temperature of 20°C to 25°C (7T). The barcode on the product is GTIn 371208808. The label cautions to keep it out of reach of children.*
71205-881-30 (Levetiracetam 07)
This is a description of Levetiracetam 750mg #30 ER Tablets, which are film-coated, oval-shaped, and white in color, with one side debossed with "*SG" and the other side debossed with "190". These tablets are manufactured by ScieGen Pharmaceuticals, Inc. and distributed by Proficient Rx LP. Each tablet contains 750 mg of Levetiracetam, USP and should be prescribed only by a physician. The medication guide enclosed with the tablets should be provided to each patient. The product ID is QL088130 and the GTIN is 0371205881306. The storage temperature is 20°-25°C (68°-77°F), and the medication should be kept out of the reach of children. The lot number is 00000, and the expiration date is not available.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
